Published by Josh White on 25th June 2024
(Sharecast News) - Shares of German chemical and pharmaceutical firm Merck were falling sharply on Tuesday, after it announced that a trial for its head and neck cancer drug xevinapant had been halted due to a lack of efficacy.
URL: http://www.digitallook.com/dl/news/story/34385478/...